Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 May 2022 for Applied Therapeutics Inc., €1,430. Read the official filing
Filing timeline
BuySaleChids Mahadevan
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Chids Mahadevan: trading record in brief
Chids Mahadevan discloses dealings in Applied Therapeutics Inc. to SEC (Form 4). Over a trading history stretching from 10 May 2021 to 16 May 2022, the count stands at 3 filings.
On the market, this insider has only sold: 1 sale, €1,430 in total. The rest of the record consists of 2 share grants. 2022 to date brings no purchases and 1 sale.
The record was last updated on 18 May 2022 with an open-market sale (€1,430) in Applied Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Chids Mahadevan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
905 shares@ US$1.65100.0% of flowCommon StockSEC:0001209191-22-030292:0
2,136 shares0Common StockSEC:0001209191-22-024536:0
8,544 shares0Common StockSEC:0001209191-21-032971:0
3 of 3 declarations
